Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Isiah Thomas Overdose Indicates Lunesta Has Chink in Armor
- Until now, Sepracor’s Lunesta sleeping pill has enjoyed one advantage over Sanofi-Aventis’s Ambien CR: a superior reputation for safety. The drug is approved by the FDA for long-term use, unlike many of its rivals. And it’s not a benzodiazepine. That reputation changed over the weekend as it...
- Blog posts 2008-10-26
Additional Resources
- Sepracor Announces 940 Layoffs; Achieves the Impossible on Lunesta Sales
- Back in August, BNET ragged on Sepracor for implementing a cost-cutting program that drove up its expenses and drove down its revenue. In its Q4 earnings today, the company has turned that all around -- sales are up and expenses are down. The turnaround has come at...
- Blog posts 2009-01-29
- << Previous
- page 1 of 1
- Next >>
